Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases May 25, 2023 Data from Across Incyte’s Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress May 23, 2023 Incyte to Present at Upcoming Investor Conferences May 8, 2023 Incyte Strengthens Research & Development Efforts Appointing Pablo J. Cagnoni, M.D. to New Leadership Role All press releases Latest Events Jun 12 2023 Jun 12 2023 Goldman Sachs Annual Global Healthcare Conference Click here for Webcast Jun 6 2023 Jun 6 2023 William Blair Annual Growth Stock Conference Click here for Webcast All events
